Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

Co-opted Pathways Required by Oncogenic KRAS to Sustain Lung Tumorigenesis Oncogenic KRAS relies on additional pathways that are engaged downstream of these effectors or are required indirectly as ...

Murine Kras-driven lung cancer models have confirmed the key requirements for RAF, PI3K and RAL-GEF in vivo. Co-opted pathways required by oncogenic KRAS in order to sustain lung tumorigenesis ...

These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...

Although activating KRAS mutations occur frequently in cancer, targeting this oncogene has proved difficult. Three groups have now identified pathways that have not been previously linked to KRAS ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Revolution Medicines (RVMD – Research ...

(Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers ...

Seventeen-year-old Raghav Gulati, from Dubai Creek Resort, marked a major achievement in his golfing career when he clinched ...

Oscar Craig (Jumeirah Golf Estates) may not have been at his best, but still did enough to take the lead in the Overall ...

Revolution Medicines (RVMD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Benjamin ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...